A Head Start: Insurance Covers Wearable for Migraines

Hey Geeks, exciting news in the world of migraine relief! Bio-electronics company, Theranica recently announced that DC Medicaid will now cover the Nerivio® REN wearable. This FDA-cleared, non-drug, and non-disruptive treatment option is a game-changer for individuals suffering from migraines, especially for adolescents and adults ages 12 and older.

A Major Win for Migraine Sufferers

The inclusion of Nerivio in DC Medicaid’s coverage is monumental, marking it as the second federally funded insurance plan to do so, following the VA. With this decision, over 300,000 DC Medicaid beneficiaries will have access to a non-invasive and drug-free solution for both acute migraine attacks and preventive care. This move not only benefits those living in the greater Washington D.C. area but also sets a precedent for other insurance providers to follow.

Benefits for Everyday Consumers

For everyday consumers, especially those battling migraines, the Nerivio wearable offers significant advantages. It provides a non-pharmacological treatment option that doesn’t disrupt daily life. By using Remote Electrical Neuromodulation (REN), Nerivio activates the body’s natural pain management mechanisms, offering relief without the side effects associated with medication. This is particularly beneficial for those who need to stay functional and present throughout their day, whether at work, school, or home.

Leading the Way in Migraine Care

DC Medicaid’s decision reflects a broader trend toward embracing innovative, non-drug treatments for migraines. Highmark Inc. and Blue Cross Blue Shield North Dakota have already recognized the clinical benefits of Nerivio, and their coverage has paved the way for other insurers. This expansion in coverage is expected to significantly improve the quality of life for many migraine sufferers, providing them with an effective and accessible treatment option.

A Brighter Future for Migraine Patients

Professor Christopher Gottschalk from Yale University and Marc DiSabella from Children’s National Hospital in Washington D.C. commend this move, highlighting its potential to set a new standard in migraine care. As more insurers follow suit, the accessibility and affordability of migraine treatments like Nerivio will continue to grow, offering hope and relief to the millions of Americans living with this debilitating condition.

For more information about the Nerivio REN wearable, visit Nerivio.com.

Source: PR Newswire 05.21.24

Follow us here on LinkedIn for bi-weekly posts or on social for the latest news and reviews on wearable tech for everyday consumers. GEEK OF CHIC® was recently ranked as one of the Top 10 Wearable Tech Magazines on the web by Feedspot.